A Director at Lannett (NYSE: LCI) is Selling Shares

Today, a Director at Lannett (LCIResearch Report), Albert Paonessa, sold shares of LCI for $203.1K.

Following Albert Paonessa’s last LCI Sell transaction on September 06, 2019, the stock climbed by 0.9%. In addition to Albert Paonessa, one other LCI executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

The company has a one-year high of $14.16 and a one-year low of $3.33.

In the last 30 days, insiders have sold $322.4K worth of LCI shares and purchased $245.5K worth of LCI shares. The insider sentiment on Lannett has been neutral according to 62 insider trades in the past three months. This sentiment is slightly lower than the average sentiment of company insiders in this sector.

Albert Paonessa’s trades have generated a 18.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.